Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life.

Houvenaghel JF, Drapier S, Duprez J, Robert GH, Riou A, Drapier D, Sauleau P, Vérin M.

J Neurol Sci. 2018 Oct 7;395:113-118. doi: 10.1016/j.jns.2018.10.010. [Epub ahead of print]

PMID:
30312901
2.

Apathy alters emotional arousal in chronic schizophrenia.

Dondaine T, Philippot P, Batail JM, Le Jeune F, Sauleau MPP, Drapier S, Vérin M, Millet MPB, Drapier D, Robert G.

J Psychiatry Neurosci. 2018 Oct 2;43(6):170172. doi: 10.1503/jpn.170172. [Epub ahead of print]

PMID:
30277457
3.

Hemispheric specialization of the basal ganglia during vocal emotion decoding: Evidence from asymmetric Parkinson's disease and 18FDG PET.

Stirnimann N, N'Diaye K, Jeune FL, Houvenaghel JF, Robert G, Drapier S, Drapier D, Grandjean D, Vérin M, Péron J.

Neuropsychologia. 2018 Oct;119:1-11. doi: 10.1016/j.neuropsychologia.2018.07.023. Epub 2018 Jul 21.

PMID:
30040955
4.

Functional atlases for analysis of motor and neuropsychological outcomes after medial globus pallidus and subthalamic stimulation.

Haegelen C, Baumgarten C, Houvenaghel JF, Zhao Y, Péron J, Drapier S, Jannin P, Morandi X.

PLoS One. 2018 Jul 13;13(7):e0200262. doi: 10.1371/journal.pone.0200262. eCollection 2018.

5.

Subthalamic deep brain stimulation influences complex emotional musical experience in Parkinson's disease.

Trost W, Leh F, Houvenaghel JF, Choppin S, Drapier S, Sauleau P, Haegelen C, Robert G, Grandjean D, Vérin M.

Neuropsychologia. 2018 Aug;117:278-286. doi: 10.1016/j.neuropsychologia.2018.06.018. Epub 2018 Jun 22.

PMID:
29936120
6.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 Jun 5;90(23):e2059-e2067. doi: 10.1212/WNL.0000000000005660. Epub 2018 May 11.

7.

Correction to: The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Auffret M, Drapier S, Vérin M.

Drugs R D. 2018 Jun;18(2):161. doi: 10.1007/s40268-018-0233-0.

8.

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Auffret M, Drapier S, Vérin M.

Drugs R D. 2018 Jun;18(2):91-107. doi: 10.1007/s40268-018-0230-3. Review. Erratum in: Drugs R D. 2018 May 8;:.

9.

Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Auffret M, Drapier S, Vérin M.

Clin Drug Investig. 2018 Apr;38(4):287-312. doi: 10.1007/s40261-018-0619-3. Review.

PMID:
29327219
10.

Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.

Duprez J, Houvenaghel JF, Drapier S, Auffret M, Drapier D, Robert G, Vérin M, Sauleau P.

J Neurol. 2018 Mar;265(3):471-477. doi: 10.1007/s00415-017-8721-7. Epub 2017 Dec 28.

11.

Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment.

Dufournet B, Nguyen K, Charles P, Grabli D, Jacquette A, Borg M, Danaila T, Mutez E, Drapier S, Colin O, Eusebio A, Philip N, Azulay JP.

Rev Neurol (Paris). 2017 Jun;173(6):406-410. doi: 10.1016/j.neurol.2017.03.021. Epub 2017 Apr 29.

12.
13.

Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.

Auffret M, Le Jeune F, Maurus A, Drapier S, Houvenaghel JF, Robert GH, Sauleau P, Vérin M.

J Neurol Sci. 2017 Jan 15;372:279-287. doi: 10.1016/j.jns.2016.11.080. Epub 2016 Dec 2.

PMID:
28017228
14.

Influence of subthalamic deep-brain stimulation on cognitive action control in incentive context.

Houvenaghel JF, Duprez J, Argaud S, Naudet F, Dondaine T, Robert GH, Drapier S, Haegelen C, Jannin P, Drapier D, Vérin M, Sauleau P.

Neuropsychologia. 2016 Oct;91:519-530. doi: 10.1016/j.neuropsychologia.2016.09.015. Epub 2016 Sep 21.

15.

Pallidal stimulation in Parkinson's patients with contraindications to subthalamic target: A 3 years follow-up.

Bonenfant J, Drapier S, Houvenaghel JF, Naudet F, Haegelen C, Sauleau P, Vérin M.

Parkinsonism Relat Disord. 2017 Jan;34:20-25. doi: 10.1016/j.parkreldis.2016.10.007. Epub 2016 Oct 11.

16.

Influence of promised rewards on conflict resolution in healthy participants and patients with Parkinson's disease.

Houvenaghel JF, Duprez J, Naudet F, Argaud S, Dondaine T, Drapier S, Robert GH, Drapier D, Vérin M, Sauleau P.

J Neurol Sci. 2016 Aug 15;367:38-45. doi: 10.1016/j.jns.2016.05.045. Epub 2016 May 24.

17.

Weight Gain following Pallidal Deep Brain Stimulation: A PET Study.

Sauleau P, Drapier S, Duprez J, Houvenaghel JF, Dondaine T, Haegelen C, Drapier D, Jannin P, Robert G, Le Jeune F, Vérin M.

PLoS One. 2016 Apr 12;11(4):e0153438. doi: 10.1371/journal.pone.0153438. eCollection 2016.

18.

Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study.

Drapier S, Eusebio A, Degos B, Vérin M, Durif F, Azulay JP, Viallet F, Rouaud T, Moreau C, Defebvre L, Fraix V, Tranchant C, Andre K, Courbon CB, Roze E, Devos D.

J Neurol. 2016 Jun;263(6):1111-9. doi: 10.1007/s00415-016-8106-3. Epub 2016 Apr 8.

PMID:
27060084
19.

A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.

Hainque E, Vidailhet M, Cozic N, Charbonnier-Beaupel F, Thobois S, Tranchant C, Brochard V, Glibert G, Drapier S, Mutez E, Doe De Maindreville A, Lebouvier T, Hubsch C, Degos B, Bonnet C, Grabli D, Legrand AP, Méneret A, Azulay JP, Bissery A, Zahr N, Clot F, Mallet A, Dupont S, Apartis E, Corvol JC, Roze E.

Neurology. 2016 May 3;86(18):1729-35. doi: 10.1212/WNL.0000000000002631. Epub 2016 Apr 6.

PMID:
27053715
20.

Pre-frontal-insular-cerebellar modifications correlate with disgust feeling blunting after subthalamic stimulation: A positron emission tomography study in Parkinson's disease.

Ory S, Le Jeune F, Haegelen C, Vicente S, Philippot P, Dondaine T, Jannin P, Drapier S, Drapier D, Sauleau P, Vérin M, Péron J.

J Neuropsychol. 2017 Sep;11(3):378-395. doi: 10.1111/jnp.12094. Epub 2015 Dec 16.

21.

Reduced Verbal Fluency following Subthalamic Deep Brain Stimulation: A Frontal-Related Cognitive Deficit?

Houvenaghel JF, Le Jeune F, Dondaine T, Esquevin A, Robert GH, Péron J, Haegelen C, Drapier S, Jannin P, Lozachmeur C, Argaud S, Duprez J, Drapier D, Vérin M, Sauleau P.

PLoS One. 2015 Oct 8;10(10):e0140083. doi: 10.1371/journal.pone.0140083. eCollection 2015.

22.

Spinal cord hemorrhage in a patient with neurosarcoidosis on long-term corticosteroid therapy: case report.

Pegat B, Drapier S, Morandi X, Edan G.

BMC Neurol. 2015 Jul 30;15:123. doi: 10.1186/s12883-015-0373-6.

23.

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.

Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, Henriksen T, Sesar Á, Poewe W; Expert Consensus Group for Use of Apomorphine in Parkinson's Disease, Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Martínez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K.

Parkinsonism Relat Disord. 2015 Sep;21(9):1023-30. doi: 10.1016/j.parkreldis.2015.06.012. Epub 2015 Jun 17. Review.

PMID:
26189414
24.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.

Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.

25.

Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease.

Langner-Lemercier S, Drapier S, Naudet F, Le Clanche N, Houvenaghel JF, Sauleau P, Jannin P, Haegelen C, Le Jeune F, Vérin M.

J Neurol. 2015;262(4):881-9. doi: 10.1007/s00415-015-7647-1. Epub 2015 Jan 30.

PMID:
25634679
26.

Weight gain following subthalamic nucleus deep brain stimulation: a PET study.

Sauleau P, Le Jeune F, Drapier S, Houvenaghel JF, Dondaine T, Haegelen C, Lalys F, Robert G, Drapier D, Vérin M.

Mov Disord. 2014 Dec;29(14):1781-7. doi: 10.1002/mds.26063. Epub 2014 Nov 7.

PMID:
25382049
27.

Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study.

Robert GH, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Péron J, Houvenaghel JF, Travers D, Sauleau P, Millet B, Vérin M, Drapier D.

Neurology. 2014 Oct 28;83(18):1620-6. doi: 10.1212/WNL.0000000000000941. Epub 2014 Sep 24.

PMID:
25253750
28.

Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudate.

Millet B, Jaafari N, Polosan M, Baup N, Giordana B, Haegelen C, Chabardes S, Fontaine D, Devaux B, Yelnik J, Fossati P, Aouizerate B, Krebs MO, Robert G, Jay T, Cornu P, Vérin M, Drapier S, Drapier D, Sauleau P, Peron J, Le Jeune F, Naudet F, Reymann JM.

Eur Neuropsychopharmacol. 2014 Aug;24(8):1229-39. doi: 10.1016/j.euroneuro.2014.05.006. Epub 2014 May 20.

29.

Pallidal stimulation in Parkinson's disease does not induce apathy.

Lozachmeur C, Drapier S, Robert G, Dondaine T, Laviolle B, Sauleau P, Peron J, Le Jeune F, Travers D, Millet B, Vérin M, Drapier D.

J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):221-6. doi: 10.1176/appi.neuropsych.13020032.

PMID:
24921969
30.

An unusual cause of acute paraplegia in a 16-year-old dancer.

Michel L, Salmon A, Malrain C, Mineur G, Gauvrit JY, Sauleau P, Morandi X, Vérin M, Edan G, Drapier S.

J Neurol. 2014 Jun;261(6):1210-2. doi: 10.1007/s00415-014-7320-0. Epub 2014 Apr 1. No abstract available.

PMID:
24687896
31.

Effect of dopamine therapy on nonverbal affect burst recognition in Parkinson's disease.

Péron J, Grandjean D, Drapier S, Vérin M.

PLoS One. 2014 Mar 20;9(3):e90092. doi: 10.1371/journal.pone.0090092. eCollection 2014.

32.

Apathy and impaired emotional facial recognition networks overlap in Parkinson's disease: a PET study with conjunction analyses.

Robert G, Le Jeune F, Dondaine T, Drapier S, Péron J, Lozachmeur C, Sauleau P, Houvenaghel JF, Travers D, Millet B, Vérin M, Drapier D.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1153-8. doi: 10.1136/jnnp-2013-307025. Epub 2014 Jan 8.

PMID:
24403280
33.

Neurological Wilson's disease lethal for the son, asymptomatic in the father.

Denoyer Y, Woimant F, Bost M, Edan G, Drapier S.

Mov Disord. 2013 Mar;28(3):402-3. doi: 10.1002/mds.25290. Epub 2013 Feb 6. No abstract available.

PMID:
23389864
34.

Anatomo-clinical atlases correlate clinical data and electrode contact coordinates: application to subthalamic deep brain stimulation.

Lalys F, Haegelen C, Mehri M, Drapier S, Vérin M, Jannin P.

J Neurosci Methods. 2013 Jan 30;212(2):297-307. doi: 10.1016/j.jneumeth.2012.11.002. Epub 2012 Nov 9.

PMID:
23147008
35.

[Psychogenic movement disorders].

Drapier S, Vérin M.

Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):662-7. doi: 10.1016/j.neurol.2012.06.010. Epub 2012 Aug 13. Review. French.

PMID:
22898562
36.

Apathy in patients with Parkinson disease without dementia or depression: a PET study.

Robert G, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Péron J, Travers D, Sauleau P, Millet B, Vérin M, Drapier D.

Neurology. 2012 Sep 11;79(11):1155-60. doi: 10.1212/WNL.0b013e3182698c75. Epub 2012 Aug 15.

PMID:
22895582
37.

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D; Parkgait-II study group.

Lancet Neurol. 2012 Jul;11(7):589-96. doi: 10.1016/S1474-4422(12)70106-0. Epub 2012 Jun 1. Erratum in: Lancet Neurol. 2012 Aug;11(8):658. Lancet Neurol. 2016 Mar;15(3):241. Lancet Neurol. 2016 Mar;15(3):241.

PMID:
22658702
38.

Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.

Drapier S, Gillioz AS, Leray E, Péron J, Rouaud T, Marchand A, Vérin M.

Parkinsonism Relat Disord. 2012 Jan;18(1):40-4. doi: 10.1016/j.parkreldis.2011.08.010. Epub 2011 Sep 3.

PMID:
21890396
39.

Subjective emotional experience at different stages of Parkinson's disease.

Vicente S, Péron J, Biseul I, Ory S, Philippot P, Drapier S, Drapier D, Vérin M.

J Neurol Sci. 2011 Nov 15;310(1-2):241-7. doi: 10.1016/j.jns.2011.06.033. Epub 2011 Jul 13.

PMID:
21741663
40.

Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation.

Rouaud T, Dondaine T, Drapier S, Haegelen C, Lallement F, Péron J, Raoul S, Sauleau P, Vérin M.

Mov Disord. 2010 Sep 15;25(12):1839-46. doi: 10.1002/mds.23171.

PMID:
20568094
41.

Mixed experimental and numerical approach for characterizing the biomechanical response of the human leg under elastic compression.

Avril S, Bouten L, Dubuis L, Drapier S, Pouget JF.

J Biomech Eng. 2010 Mar;132(3):031006. doi: 10.1115/1.4000967.

PMID:
20459194
42.

Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease.

Péron J, Le Jeune F, Haegelen C, Dondaine T, Drapier D, Sauleau P, Reymann JM, Drapier S, Rouaud T, Millet B, Vérin M.

PLoS One. 2010 Mar 29;5(3):e9919. doi: 10.1371/journal.pone.0009919.

43.

Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study.

Le Jeune F, Péron J, Grandjean D, Drapier S, Haegelen C, Garin E, Millet B, Vérin M.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1512-20. doi: 10.1007/s00259-010-1436-y. Epub 2010 Mar 28.

PMID:
20349231
44.

Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease.

Péron J, Biseul I, Leray E, Vicente S, Le Jeune F, Drapier S, Drapier D, Sauleau P, Haegelen C, Vérin M.

Neuropsychology. 2010 Jan;24(1):1-8. doi: 10.1037/a0017433.

PMID:
20063943
45.

Recognition of emotional prosody is altered after subthalamic nucleus deep brain stimulation in Parkinson's disease.

Péron J, Grandjean D, Le Jeune F, Sauleau P, Haegelen C, Drapier D, Rouaud T, Drapier S, Vérin M.

Neuropsychologia. 2010 Mar;48(4):1053-62. doi: 10.1016/j.neuropsychologia.2009.12.003. Epub 2009 Dec 11.

PMID:
20005239
46.

Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.

Le Jeune F, Drapier D, Bourguignon A, Péron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Vérin M.

Neurology. 2009 Nov 24;73(21):1746-51. doi: 10.1212/WNL.0b013e3181c34b34.

PMID:
19933975
47.

Bilateral subthalamotomy through dbs electrodes: A rescue option for device-related infection.

Deligny C, Drapier S, Verin M, Lajat Y, Raoul S, Damier P.

Neurology. 2009 Oct 13;73(15):1243-4. doi: 10.1212/WNL.0b013e3181bbfedd. No abstract available.

PMID:
19822876
48.

Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease.

Sauleau P, Leray E, Rouaud T, Drapier S, Drapier D, Blanchard S, Drillet G, Péron J, Vérin M.

Mov Disord. 2009 Oct 30;24(14):2149-55. doi: 10.1002/mds.22765.

PMID:
19735089
49.

Subthalamic nucleus stimulation affects subjective emotional experience in Parkinson's disease patients.

Vicente S, Biseul I, Péron J, Philippot P, Drapier S, Drapier D, Sauleau P, Haegelen C, Vérin M.

Neuropsychologia. 2009 Jul;47(8-9):1928-37. doi: 10.1016/j.neuropsychologia.2009.03.003. Epub 2009 Mar 13.

PMID:
19428425
50.

Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.

Péron J, Vicente S, Leray E, Drapier S, Drapier D, Cohen R, Biseul I, Rouaud T, Le Jeune F, Sauleau P, Vérin M.

Neuropsychologia. 2009 Jan;47(2):406-14. doi: 10.1016/j.neuropsychologia.2008.09.008. Epub 2008 Sep 18.

PMID:
18845171

Supplemental Content

Loading ...
Support Center